February 16, 2024Open Access

Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker

WYWei YangChildren's National ZLZhidong LiuMeizhou City People's Hospital TLTing LiuCapital Medical University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

CANT1, calcium-activated nucleotidase 1, was reported to be upregulated in certain tumors. However, the function mechanism of CANT1 in pan-cancer is still unclear.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Yang et al. (Fri,) studied this question.

synapsesocial.com/papers/68e78d00b6db6435876ff30a https://doi.org/https://doi.org/10.1016/j.cellsig.2024.111107

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment2019 · 124 citations
2The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia2004 · 343 citations
3UALCAN: An update to the integrated cancer data analysis platform2022 · 2,566 citations
4A Digest on the Role of the Tumor Microenvironment in Gastrointestinal Cancers2010 · 37 citations
5Landscape of Microsatellite Instability Across 39 Cancer Types2017 · 1,509 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo